Literature DB >> 15860345

Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.

Matthew L MacDonald1, Molly E Eaton, Joshua T Dudman, Christine Konradi.   

Abstract

BACKGROUND: Molecular adaptations are believed to contribute to the mechanism of action of antipsychotic drugs (APDs). We attempted to establish common gene regulation patterns induced by chronic treatment with APDs.
METHODS: Gene expression analysis was performed with the Affymetrix U34A array in the frontal cortex (FC) and the striatum of rats chronically treated with two concentrations of either clozapine or haloperidol. Key data were verified with real-time quantitative polymerase chain reaction.
RESULTS: Many genes in the FC affected by APD-treatment contribute to similar functions. mRNAs coding for synaptic vesicle docking- and microtubule-associated proteins were upregulated; mRNAs for serine-threonine protein phosphatases were downregulated, whereas the serine-threonine kinases protein kinase A, protein kinase C, and calcium/calmodulin kinase II alpha and IV were upregulated, indicating increased potential for protein phosphorylation. In the striatum, altered gene expression was less focused on genes of particular function or location, and the high concentration of haloperidol had a different gene expression profile than any of the other APD treatments.
CONCLUSION: We found an increase in the transcription of genes coding for proteins involved in synaptic plasticity and synaptic activity in the FC. We furthermore found that the gene expression profile of APDs is different between FC and striatum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860345      PMCID: PMC2734482          DOI: 10.1016/j.biopsych.2005.01.022

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  80 in total

Review 1.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

2.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.

Authors:  Victor Z Chong; L Trevor Young; Ram K Mishra
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

4.  Fusion of cells by flipped SNAREs.

Authors:  Chuan Hu; Mahiuddin Ahmed; Thomas J Melia; Thomas H Söllner; Thomas Mayer; James E Rothman
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

Review 5.  Antipsychotic treatment in schizophrenia: atypical options and NICE guidance.

Authors:  Ann M Mortimer
Journal:  Eur Psychiatry       Date:  2003-08       Impact factor: 5.361

6.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

Review 7.  Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

Review 8.  Understanding the new and evolving profile of adverse drug effects in schizophrenia.

Authors:  Donna A Wirshing; Joseph M Pierre; Stephen M Erhart; Jennifer A Boyd
Journal:  Psychiatr Clin North Am       Date:  2003-03

Review 9.  Clozapine: a clinical review of adverse effects and management.

Authors:  Mohammad Masud Iqbal; Atiq Rahman; Zahid Husain; Syed Zaber Mahmud; Wlliam G Ryan; Jacqueline M Feldman
Journal:  Ann Clin Psychiatry       Date:  2003-03       Impact factor: 1.567

10.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data.

Authors:  Scott W Doniger; Nathan Salomonis; Kam D Dahlquist; Karen Vranizan; Steven C Lawlor; Bruce R Conklin
Journal:  Genome Biol       Date:  2003-01-06       Impact factor: 13.583

View more
  27 in total

1.  Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.

Authors:  Alice Y Wang; Kathryn M Lohmann; C Kevin Yang; Eric I Zimmerman; Harry Pantazopoulos; Nicole Herring; Sabina Berretta; Stephan Heckers; Christine Konradi
Journal:  Acta Neuropathol       Date:  2011-10-04       Impact factor: 17.088

Review 2.  Integrated approaches to understanding antipsychotic drug action at GPCRs.

Authors:  Nikhil M Urs; Peter J Nicholls; Marc G Caron
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

Review 3.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

4.  Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.

Authors:  Paul D Shilling; Richard L Saint Marie; Jody M Shoemaker; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

5.  Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats.

Authors:  Martina von Wilmsdorff; Fabian Manthey; Marie-Luise Bouvier; Oliver Staehlin; Peter Falkai; Eva Meisenzahl-Lechner; Andrea Schmitt; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-05       Impact factor: 5.270

6.  Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.

Authors:  Rachael M Youngs; Melissa S Chu; Edward G Meloni; Alipi Naydenov; William A Carlezon; Christine Konradi
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

7.  AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.

Authors:  J A O'Connor; E C Muly; S E Arnold; S E Hemby
Journal:  Schizophr Res       Date:  2006-12-01       Impact factor: 4.939

8.  Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.

Authors:  Tai-Xiang Xu; Tatyana D Sotnikova; Chengyu Liang; Jingping Zhang; Jae U Jung; Roger D Spealman; Raul R Gainetdinov; Wei-Dong Yao
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

9.  Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.

Authors:  José L Moreno; Terrell Holloway; Adrienne Umali; Vinayak Rayannavar; Stuart C Sealfon; Javier González-Maeso
Journal:  Psychopharmacology (Berl)       Date:  2012-07-28       Impact factor: 4.530

10.  Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex.

Authors:  Se Hyun Kim; Hyun Sook Yu; Hong Geun Park; Soyoung Park; Myoung Suk Seo; Won Je Jeon; Yong Min Ahn; Kyooseob Ha; Soon Young Shin; Yong Sik Kim
Journal:  Psychopharmacology (Berl)       Date:  2013-06-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.